Thank you, Mr. Chairman.
Thank you very much for your presentation today. We've heard some things that I don't think I've heard before.
Dr. Morgan, I'm going to direct my comments to you first. You said in your presentation that the CDR has rapidly become a respected peer among review processes on the global stage. It's something I don't think I've heard before from the presenters we've had.
We're heard there's non-accountability, duplication, and no transparency. It's focused on cost containment rather than benefit. There's a lack of an appeal process. But in all fairness, they're not comparing it to the global stage. Could you make some comments in reference to that? Why is it looked at so much differently globally than it is internally?